This is for a senior seminar research paper, and the sources included should mostly be primary research articles. Citations style is CSE format.
Some articles could be:
Aggarwal S, Pittenger MF. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Ameri Soci Hema. [published 2005 Feb 15]. [cited 2024 March 15]; 105(4):1815-1822. Available from: https://www.sciencedirect.com/science/article/pii/S0006497120459130
Arruda LCM, Malmegrim KCR, Lima-Junior J, Clave E, Dias JBE, Moraies DA, Douay C, Fournier I, Moins-Teisserence H, Alberdi AJ, Covas DT, Simoes BP, Lansiaux P, Toubert A, Oliveira MC. 2018. Immune rebound is associated with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Ameri Soci Hema. [published 2018 Jan 23]. [cited 2024 March]; 2(2)126-141. Available from: https://doi.org/10.1182/bloodadvances.2017011072
Alexander T, Farge D, Badoglio M, Lindsay JO, Muraro PA, Snowden JA. 2018. Hematopoietic stem cell therapy for autoimmune diseases- Clinical experience and mechanisms. Jour Autoimm. [published 2018 Aug]. [cited 2024 March 13]; 92:35-46. Available from: https://doi.org/10.1016/j.jaut.2018.06.002
Chu DT, Nguyen TT, Le Bao Tien N, Tran DK, Jeong JH, Anh PG, Thanh VV, Truong DT, Dinh TC. 2020. Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications. Cells. [internet 2020 Feb 28]. [cited 2024 Mar]; 9(3)563. Available from: https://doi.org/10.3390/cells9030563
Stem Cell Transplants in Cancer Treatment. [Internet]. [updated 2023 Oct 5]. Bethesda (MD): National Cancer Institute; [cited 2024 Feb 29]. Available from: https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant